0000899243-21-000453.txt : 20210105
0000899243-21-000453.hdr.sgml : 20210105
20210105181438
ACCESSION NUMBER: 0000899243-21-000453
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210104
FILED AS OF DATE: 20210105
DATE AS OF CHANGE: 20210105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Malik Rajesh
CENTRAL INDEX KEY: 0001706853
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 21507770
MAIL ADDRESS:
STREET 1: 79 TW ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 PARK OFFICES DRIVE
STREET 2: SUITE 200
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: 700 PARK OFFICES DRIVE
STREET 2: SUITE 200
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-04
0
0001560241
G1 Therapeutics, Inc.
GTHX
0001706853
Malik Rajesh
C/O G1 THERAPEUTICS
700 PARK OFFICES DR, SUITE 200
RESEARCH TRIANGLE PARK
NC
27709
0
1
0
0
Chief Medical Officer
Common Stock
2021-01-04
4
A
0
11000
0.00
A
40200
D
Stock Options (Right to Buy)
18.07
2021-01-04
4
A
0
58000
0.00
A
2031-01-04
Common Stock
58000
58000
D
Represents a restricted stock unit ("RSU") award that vests 25% on January 4, 2022 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
Each RSU represents a contingent right to receive one share of Issuer common stock.
Represents 29,200 shares of common stock and 11,000 restricted stock units
The shares underlying this option vest as to 25% of the shares on January 4, 2022, with the remainder vesting in 36 equal installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
/s/ James Stillman Hanson, attorney-in-fact
2021-01-05